Brought to you by:
Global perspectives take center stage in second annual WFVS session at VAM
“The intellectual exchange of information and a better understanding of unique global perspectives has brought the leading societies closer,” Palma Shaw, MD, MBA, secretary general of the World Federation of Vascular Societies (WFVS) says of the success of this international…
NESVS Robert R. Linton Lecture features complex aortic masterclass from Europe
World-leading aortic surgeon Stéphan Haulon, MD, from the Aortic Centre at Hôpital Marie Lannelongue in Paris, France, took attendees of the 2022 New England Society for Vascular Surgery (NESVS) annual meeting on a whirlwind, 15-year journey through the evolution of…
Terumo Aortic announces new technology add-on payment for Thoraflex Hybrid device in US
The Centers for Medicare and Medicaid Services (CMS) has granted approval of a new technology add-on payment (NTAP) for Terumo Aortic’s Thoraflex Hybrid device—used to treat aortic arch disease—under the inpatient prospective payment system (IPPS). The add-on payment is effective…
Terumo Aortic announces first commercial implant of Thoraflex Hybrid in US
Following the recent approval by the Food and Drug Administration (FDA) of the Thoraflex Hybrid frozen elephant trunk (FET) device for the treatment of patients with complex aortic arch disease, Terumo Aortic has now announced the first commercial implant of…
Terumo Aortic announces FDA approval for Thoraflex Hybrid frozen elephant trunk device
Terumo Aortic today announced that the Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid frozen elephant trunk device for commercial sale in the U.S. for the treatment of patients with complex aortic arch disease. Thoraflex Hybrid…
Summit to discuss aortic arch: The ‘next new frontier’
This year’s Vascular Annual Meeting (VAM) Aortic Summit will focus on the “next new frontier” in vascular surgery—endovascular treatment of the aortic arch. “We want to push the frontier to treat more patients. The arch is the Achilles’ heel of…
Total endovascular aortic arch treatment shows promise in dissections, but secondary interventions remain ‘Achilles’ heel’
Speaking at the Virtual Aortic Surgery How to Do It Highlights conference (Dec. 17–18), Stéphan Haulon, MD, a vascular surgeon at Hôpital Marie Lannelongue, Paris, France, discussed total endovascular treatment of the aortic arch in chronic dissections. Detailing global experience…
Ascending aorta: Challenges of obtaining data discussed at CX Aortic Vienna
In the ascending aorta session at CX Aortic Vienna, presentations focused on various treatment options, including frozen elephant trunk (FET) and endovascular intervention. The panelists emphasized the scarcity of data in this zone and called for data gathering. Simultaneously, the…
Endovascular aortic arch repair with three-vessel inner branches is safe, investigators find
Total endovascular aortic arch repair for aneurysms and chronic dissections using three-vessel inner branch stent-grafts is technically feasible and safe, a multicenter global early feasibility study finds. “Mortality and stroke rates compare favorably to reported outcomes of total open surgical…
CX 2020 LIVE aortic arch discussion highlights importance of underlying pathology and benefit of multidisciplinary team
Last week, the CX 2020 LIVE agenda turned to the technically challenging topic of aortic arch interventions. Through presentations, discussion, and polling, the session—chaired by Roger Greenhalgh (London, UK) and moderated by Stéphan Haulon (Paris, France)—aimed to tackle some vital…